On May 24, Dr. Jiang Dawei from Laboratory of Molecular Imaging and Nanotechnology of Department of Imaging, University of Wisconsin-Madison (UW-Madison), was invited by Department of Medical Imaging of the First Affiliated Hospital of Xi’an Jiaotong University to visit the research platform and deliver academic exchanges.

In the keynote speech, Dr. Jiang introduced the technical features of in vivo, noninvasive and quantitative positron emission tomography (PET), demonstrating the researches related to the construction of high-performance probes for biological macromolecules (such as antibodies and oligonucleotide chains, etc.) based on advanced molecular imaging platforms. Besides, he also summarized relevant studies on clinical application of positron-emitting radionuclide labeled therapeutic antibodies, preparation of tumor-targeted PET probes and in vivo evaluation.

The keynote speech delivered by Dr. Jiang illustrates the relevant cutting-edge technologies which lead the development of molecular imaging and provides novel ideas and perspectives on how to extensively respond to the individualized diagnosis and treatment requirements in clinical practice and how to launch interdisciplinary research.

Dr. Liu Siyun, Senior Program Officer of Transformational Medicine of General Electric (GE) Healthcare, introduced the expertise and supports provided by GE research team to assist the customers in conducting molecular imaging and translational medicine research, highlighting the research progress on PET/magnetic resonance imaging (PET/MR) probes.

This academic exchange has expanded the knowledge system of clinicians at the basic research level of molecular imaging and laid a solid foundation for potential research cooperation and talent introduction in the future.